ROSIA Positioning paper

Puntos clave

• The aim is to explore regulatory and evaluative challenges of digital therapeutics in isolated areas and suggest improvements.
• Analysis of the current state of digital therapeutics in Europe
• Evaluation of existing regulatory frameworks
• Development of policy recommendations for better integration into healthcare systems
• Identification of key barriers to the adoption of digital therapeutics
• Proposed recommendations for policy changes to enhance acceptance
• Insights into the regulatory landscape for digital therapeutics in Europe

Resumen